CA2485983A1 - Cancer-linked gene as target for chemotherapy - Google Patents

Cancer-linked gene as target for chemotherapy Download PDF

Info

Publication number
CA2485983A1
CA2485983A1 CA 2485983 CA2485983A CA2485983A1 CA 2485983 A1 CA2485983 A1 CA 2485983A1 CA 2485983 CA2485983 CA 2485983 CA 2485983 A CA2485983 A CA 2485983A CA 2485983 A1 CA2485983 A1 CA 2485983A1
Authority
CA
Canada
Prior art keywords
cancer
gene
process
cell
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2485983
Other languages
French (fr)
Inventor
Reinhard Ebner
Stephen K. Horrigan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Avalon Pharmaceuticals Inc
Original Assignee
Avalon Pharmaceuticals
Reinhard Ebner
Stephen K. Horrigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US38061202P priority Critical
Priority to US60/380,612 priority
Application filed by Avalon Pharmaceuticals, Reinhard Ebner, Stephen K. Horrigan filed Critical Avalon Pharmaceuticals
Priority to PCT/US2003/015314 priority patent/WO2003097803A2/en
Publication of CA2485983A1 publication Critical patent/CA2485983A1/en
Application status is Abandoned legal-status Critical

Links